Clinical Trial Update: Combination Chemotherapy With or Without Monoclonal Antibody Therapy in Treating Older Patients With Non-Hodgkin's Lymphoma [Phase 3]

View source ↗

Summary

A Phase 3 trial evaluating adding monoclonal antibody therapy to chemotherapy in older patients with Non-Hodgkin's lymphoma has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Non-hodgkin Lymphoma

Snippet

Sponsor: Eastern Cooperative Oncology Group | Conditions: Lymphoma | Phase 3 | Status: COMPLETED